Catechol

Catechol

SCHEMBL27085

CCOCC.Oc1ccccc1O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.56
CA12 O43570 3/20 0.56
CA14 Q9ULX7 3/20 0.56
LMNA P02545 3/20 0.56
ALDH1A1 P00352 3/20 0.56
MAPT P10636 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
KDM4E B2RXH2 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALOX15 P16050 2/20 0.56
NPC1 O15118 1/20 0.56
GMNN O75496 1/20 0.56
EGFR P00533 1/20 0.56
FYN P06241 1/20 0.56
POLB P06746 1/20 0.56
CA3 P07451 1/20 0.56
CYP3A4 P08684 1/20 0.56
MMP9 P14780 1/20 0.56
HPGD P15428 1/20 0.56
NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Catechol SCHEMBL5431374 1.00 CA2 (0.56) CA2CA12CA14LMNAALDH1A1
Catechol SCHEMBL9616729 0.95 CA2 (0.50) CA2CA12CA14LMNAALDH1A1
Catechol SCHEMBL11555211 0.87 ALDH1A1 (0.48) CA2CA12CA14LMNAALDH1A1
Ether SCHEMBL5662397 0.87 ALDH1A1 (0.46) CA2CA12CA14LMNAALDH1A1
Catechol SCHEMBL11651447 0.87 ALDH1A1 (0.48) CA2CA12CA14LMNAALDH1A1
Resorcinol SCHEMBL14332270 0.87 CA12 (0.50) CA2CA12CA14LMNAALDH1A1
Orthocresol SCHEMBL8400076 0.85 CA2 (0.45) CA2CA12CA14LMNAALDH1A1
Pyrogallol SCHEMBL3175241 0.84 CA1 (0.60) CA2CA12CA14LMNAALDH1A1
Ether SCHEMBL8042799 0.84 HSPA5 (0.50) CA2CA12CA14MAPTHIF1A
Ether SCHEMBL9754657 0.84 HPGD (0.41) CA2CA12CA14LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12548798-B2 Hydrofluorocarbon (HFC)-based safe electrolyte for secondary batteries BATTELLE MEMORIAL INSTITUTE (US) 2026-02-10 US claimed
CN-120136683-A Catechol ether compound, pharmaceutical composition and application thereof 中国药科大学 2025-06-13 CN claimed
CN-117964812-A Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964813-A Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964814-A Ziegler-Natta solid catalyst component, catalyst and application thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
US-11831017-B2 Redox flow battery electrolytes CMBLU ENERGY AG (DE) 2023-11-28 US claimed
WO-2023127538-A1 LIQUID CRYSTALLINE COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC LAYER, OPTICAL ELEMENT AND LIGHT GUIDE ELEMENT 富士フイルム株式会社 2023-07-06 WO claimed
CN-112723998-A Preparation method of o-dimethyl ether 锦州三丰科技有限公司 2021-04-30 CN claimed
US-10252850-B2 Catalytic oxidation/reduction compositions and articles MULTISORB TECHNOLOGIES, INC. (US) 2019-04-09 US claimed
CN-109369541-A A kind of catechol ether chain bridging allophanamide yl pyrimidines ketone compound and its synthetic method 常州大学 2019-02-22 CN claimed
WO-2004067006-A1 COMBINATION OF A PDE IV INHIBITOR AND A TNF-ALPHA ANTAGONIST PHARMACIA CORPORATION (US) 2004-08-12 WO claimed
CN-1247851-A Improved 3-ethoxy-4-hydroxyl benzaldehyde preparing process HU KANG (CN) 2000-03-22 CN claimed
US-5945501-A Epoxy resin compositions including novel phenol novolak condensates produced from bis(methoxymethyl)biphenyls UBE INDUSTRIES, LTD. (JP) 1999-08-31 US claimed
US-5612442-A Phenol novolak condensate and bis(methoxymethyl)biphenyl for production thereof UBE INDUSTRIES, LTD. (JP) 1997-03-18 US claimed
US-4816592-A Process for the production of certain 2,3-dihydro-benzofuran derivatives ENICHEM SINTESI SPA (IT) 1989-03-28 US claimed
EP-0115837-B1 PROCESS FOR THE PRODUCTION OF BENZOFURAN DERIVATIVES ENICHEM SYNTHESIS S.p.A. (IT) 1988-03-16 EP claimed
EP-0068250-B1 DIOXYBENZENE ETHER DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE BAYER AG (DE) 1986-02-26 EP claimed
EP-0115837-A1 Process for the production of benzofuran derivatives ENICHEM SYNTHESIS S.p.A. (IT) 1984-08-15 EP claimed
US-4140725-A CHEMICAL INTERMEDIATES FOR INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 1979-02-20 US claimed
US-4025566-A Process for preparing monoalkyl ethers of dihydric phenols UBE INDUSTRIES, LTD. (JA) 1977-05-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12548798-B2 Hydrofluorocarbon (HFC)-based safe electrolyte for secondary batteries SLC9A2, SLC9A1, SLC9A3 CA2 58/4885CA12 151/4885CA14 459/4885
US-11831017-B2 Redox flow battery electrolytes GPX1, GPX4, NOX4 CA2 387/4885CA12 466/4885CA14 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.